# Cervical Preparation With Mifepristone Prior to Osmotic Dilators

> **NCT03714880** · PHASE2 · TERMINATED · sponsor: **University of California, Davis** · enrollment: 44 (actual)

## Conditions studied

- Second Trimester Abortion

## Interventions

- **DRUG:** Mifepristone 200 MG
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03714880
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-26
- **Primary completion:** 2021-02-26
- **Final completion:** 2021-02-26
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** Slow recruitment compounded by COVID-19
- **Last updated:** 2022-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03714880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03714880, "Cervical Preparation With Mifepristone Prior to Osmotic Dilators". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03714880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*